Skin care

Phio Pharmaceuticals Reports 2023 Year End Financial Results and Provides Business Update

Retrieved on: 
Tuesday, April 2, 2024

MARLBOROUGH, Mass., April 02, 2024 (GLOBE NEWSWIRE) -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a clinical stage biotechnology company whose proprietary INTASYL™ RNAi platform technology is designed to make immune cells more effective in killing tumor cells, today reported its financial results for the year ended December 31, 2023 and provided a business update.

Key Points: 
  • The latter clearance was significant since there are no drugs specifically approved to treat early stages I and II of cSCC.
  • As of February, the first two patients in our first cohort have completed treatment with PH-762 with no reported adverse events.
  • In 2023 we implemented a cost rationalization program driven by our transition from discovery research to product development.
  • At December 31, 2023 we had cash of $8.5 million as compared with $11.8 million at December 31, 2022.

New Zealand Mānuka Honey: Science Confirms Genetic Uniqueness And Urges Informed Choices For Consumers

Retrieved on: 
Thursday, March 28, 2024

This news empowers consumers to make informed choices when seeking genuine mānuka honey with its renowned antibacterial, anti-inflammatory, and antioxidant properties.

Key Points: 
  • This news empowers consumers to make informed choices when seeking genuine mānuka honey with its renowned antibacterial, anti-inflammatory, and antioxidant properties.
  • The Unique Mānuka Factor Honey Association (UMFHA), the trusted leader in mānuka honey quality and authentication, applauds the clarity for consumers of these latest findings.
  • The findings confirmed that mānuka trees from New Zealand and Tasmania (Australia) are genetically distinct enough to be considered separate species.
  • "Consumers choosing mānuka honey for its health benefits need accurate information to select the ideal product," says Tony Wright, CEO of the UMFHA.

Waldencast Class Action Investigation: Johnson Fistel, LLP is Investigating for Violation of Securities Laws; WALD, WALDW

Retrieved on: 
Thursday, March 21, 2024

The investigation focuses on investors’ losses and whether they may be recovered under federal securities laws.

Key Points: 
  • The investigation focuses on investors’ losses and whether they may be recovered under federal securities laws.
  • What if I purchased Waldencast securities?
  • If you purchased securities and suffered significant losses on your investment, join our investigation now:
    Or for more information, contact Jim Baker at [email protected] or (619) 814-4471.
  • Individuals with nonpublic information regarding the company should consider whether to assist our investigation or take advantage of the SEC Whistleblower program.

Johnson Fistel, LLP is Investigating Waldencast for Violation of Securities Laws (WALD, WALDW)

Retrieved on: 
Tuesday, March 19, 2024

SAN DIEGO, March 19, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating whether Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), any of its executive officers or others violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors.

Key Points: 
  • SAN DIEGO, March 19, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating whether Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), any of its executive officers or others violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors.
  • The investigation focuses on investors’ losses and whether they may be recovered under federal securities laws.
  • What if I purchased Waldencast securities?
  • If you purchased securities and suffered significant losses on your investment, join our investigation now:
    Or for more information, contact Jim Baker at [email protected] or (619) 814-4471.

Korea Cosmetics (K-Beauty) Market Analysis Report 2024-2029: Brands are Losing Out in the Chinese Market to Local Players in the Mass Segment and to Global Players in the Premium Segment - ResearchAndMarkets.com

Retrieved on: 
Thursday, April 4, 2024

The Korea cosmetics market value stood at US$6.57 billion in 2023, and is expected to reach US$9.05 billion by 2029.

Key Points: 
  • The Korea cosmetics market value stood at US$6.57 billion in 2023, and is expected to reach US$9.05 billion by 2029.
  • Geographically, the market is not limited to a specific region within Korea but has a significant presence throughout the country.
  • Korean brands are losing out in the Chinese market to local brands in the mass segment and to global players in the premium segment, leading to inevitable and painful restructuring.
  • The report provides the bifurcation of the Korea cosmetics market into two segments based on category, premium products and mass products.

Global Skin Toner Market Analysis Report, 2023-2024 and 2029 - Surging Trend of Diversity and Inclusivity and Accelerating Popularity of Online Shopping and E-Commerce Platforms - ResearchAndMarkets.com

Retrieved on: 
Friday, March 22, 2024

The global skin toners market was valued at US$1.31 billion in 2023 and is expected to reach US$1.73 billion by 2029.

Key Points: 
  • The global skin toners market was valued at US$1.31 billion in 2023 and is expected to reach US$1.73 billion by 2029.
  • The global skin toners market is extremely competitive and consists of various global and regional players.
  • Looking ahead, the skin toners market is expected to continue its growth trajectory for several reasons.
  • One notable aspect of the skin toners market is the growing awareness regarding skincare and protection among the millennial population, across the world, in the recent years.

Johnson Fistel, LLP is Investigating Waldencast for Violation of Securities Laws; WALD, WALDW

Retrieved on: 
Thursday, March 21, 2024

Shareholder rights law firm Johnson Fistel, LLP is investigating whether Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), any of its executive officers or others violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors.

Key Points: 
  • Shareholder rights law firm Johnson Fistel, LLP is investigating whether Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), any of its executive officers or others violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors.
  • The investigation focuses on investors’ losses and whether they may be recovered under federal securities laws.
  • What if I purchased Waldencast securities?
  • If you purchased securities and suffered significant losses on your investment, join our investigation now:
    Or for more information, contact Jim Baker at [email protected] or (619) 814-4471.

Borghese Announces Appointment of Dawn Hilarczyk as Chief Operating Officer

Retrieved on: 
Thursday, March 14, 2024

Borghese , the iconic skin care brand best known for pioneering the mask category, is proud to announce the appointment of Dawn Hilarczyk as Chief Operating Officer (COO).

Key Points: 
  • Borghese , the iconic skin care brand best known for pioneering the mask category, is proud to announce the appointment of Dawn Hilarczyk as Chief Operating Officer (COO).
  • View the full release here: https://www.businesswire.com/news/home/20240314602588/en/
    “We are very pleased to appoint Dawn to the newly created role of COO,” said Steve Pfeiffer, CEO of Borghese Group.
  • “Ours is an iconic brand that was founded by Princess Marcella Borghese, is steeped in Italian heritage, and offers legendary and effective products.
  • “I am excited to take on the role of COO and eager to rejuvenate Borghese into its former beauty powerhouse status.

Perfect Corp. Launches Highly Sought-After CRM Upgrade to Skincare Pro, the Holistic AI Skin Scanner Solution

Retrieved on: 
Tuesday, March 12, 2024

The all-new cloud-based CRM features include Customer Profile Management, Automatic Skin Report History, Before-and-After Comparison, Cloud Dashboard, and Remote Management.

Key Points: 
  • The all-new cloud-based CRM features include Customer Profile Management, Automatic Skin Report History, Before-and-After Comparison, Cloud Dashboard, and Remote Management.
  • View the full release here: https://www.businesswire.com/news/home/20240312144423/en/
    Perfect Corp. Launches Highly Sought-After CRM Upgrade to Skincare Pro, the Holistic AI Skin Scanner Solution (Graphic: Business Wire)
    The new CRM upgrade for Perfect Corp's Skincare Pro app revolutionizes skincare management for medspas and clinics, allowing for comprehensive customer profile management, treatment progress tracking, and enhanced communication capabilities.
  • Previously, the Skincare Pro app provided valuable one-time skin analyses for clients, offering them insight into their skin health at a specific moment.
  • The Skincare Pro app with integrated CRM is available now for download on iOS devices, empowering skincare professionals to embrace the future of personalized skin care: https://www.perfectcorp.com/business/solutions/online-service/skincare-pro

Distinctive Dermatology Introduces Cutting-Edge Technology to Reverse Aging Without Pain or Downtime

Retrieved on: 
Wednesday, April 3, 2024

Data shows for most effective results in reducing wrinkles, lifting muscles, and improving facial tone, patients need four treatments of EMface -- one per week.  Optimal results are noticeable 6 to 12 weeks after four treatments.

Key Points: 
  • ST. LOUIS, April 3, 2024 /PRNewswire/ -- Distinctive Dermatology , a leading St. Louis-area dermatology practice, is the first to offer groundbreaking technology that reverses aging and reduces wrinkles without discomfort, needles, or downtime.
  • The clinic is hosting "Hello Spring," a complimentary beauty/makeover event on April 11 for those who want to try it.
  • "EMface is the wave of the future for those wanting to reverse aging," says Angela Sutton, D.O.
  • Distinctive Dermatology provides medical and surgical care to patients with skin conditions, and cosmetic procedures to those wanting lifelong healthy skin.